4-AMINOPYRIDINE IN MULTIPLE-SCLEROSIS

被引：1
|
作者：
POLMAN, CH
VANDIEMEN, HAM
VANDONGEN, MMMM
KOETSIER, JC
VANLOENEN, AC
VANWALBEEK, HK
机构：
[1] FREE UNIV AMSTERDAM HOSP,DEPT MED PHYS,AMSTERDAM,NETHERLANDS
[2] FREE UNIV AMSTERDAM HOSP,DEPT PHARM,AMSTERDAM,NETHERLANDS
[3] ONZE LIEVE VROUW HOSP,DEPT NEUROL,AMSTERDAM,NETHERLANDS
来源：
ANNALS OF NEUROLOGY | 1990年 / 28卷 / 04期
关键词：
D O I：
10.1002/ana.410280421
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：589 / 589
页数：1
相关论文
共 50 条
  • [11] A COMPARISON BETWEEN 4-AMINOPYRIDINE AND 3,4-DIAMINOPYRIDINE IN THE TREATMENT OF MULTIPLE-SCLEROSIS
    BERTELSMANN, FW
    POLMAN, CH
    VANDIEMEN, HAM
    DEWAAL, R
    KOETSIER, JC
    ANNALS OF NEUROLOGY, 1992, 32 (02) : 256 - 256
  • [12] THE PHARMACOKINETICS AND TOLERABILITY OF A SLOW-RELEASE FORMULATION OF 4-AMINOPYRIDINE IN MULTIPLE-SCLEROSIS PATIENTS
    BEVER, CT
    YOUNG, D
    TIERNEY, D
    CONWAY, K
    KATZ, E
    COSTELLO, K
    FOSSLER, M
    JOHNSON, KP
    NEUROLOGY, 1995, 45 (04) : A351 - A351
  • [13] THE EFFECTS OF 4-AMINOPYRIDINE ON COGNITIVE FUNCTION IN PATIENTS WITH MULTIPLE-SCLEROSIS - A PILOT-STUDY
    SMITS, RCF
    EMMEN, HH
    BERTELSMANN, FW
    KULIG, BM
    VANLOENEN, AC
    POLMAN, CH
    NEUROLOGY, 1994, 44 (09) : 1701 - 1705
  • [14] 4-AMINOPYRIDINE IN THE TREATMENT OF PATIENTS WITH MULTIPLE-SCLEROSIS - LONG-TERM EFFICACY AND SAFETY
    POLMAN, CH
    BERTELSMANN, FW
    VANLOENEN, AC
    KOETSIER, JC
    ARCHIVES OF NEUROLOGY, 1994, 51 (03) : 292 - 296
  • [15] 4-AMINOPYRIDINE IS SUPERIOR TO 3,4-DIAMINOPYRIDINE IN THE TREATMENT OF PATIENTS WITH MULTIPLE-SCLEROSIS
    POLMAN, CH
    BERTELSMANN, FW
    DEWAAL, R
    VANDIEMEN, HAM
    UITDEHAAG, BMJ
    VANLOENEN, AC
    KOETSIER, JC
    ARCHIVES OF NEUROLOGY, 1994, 51 (11) : 1136 - 1139
  • [16] Decreased relapses of multiple sclerosis in patients on 4-aminopyridine
    Stefoski, D
    Katsamakis, G
    Ko, M
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S272 - S273
  • [17] Enhancing Neural Transmission in Multiple Sclerosis (4-Aminopyridine Therapy)
    Andrew D. Goodman
    Robert Thompson Stone
    Neurotherapeutics, 2013, 10 : 106 - 110
  • [18] 4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review
    Jensen, Henrik Boye
    Ravnborg, Mads
    Dalgas, Ulrik
    Stenager, Egon
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2014, 7 (02) : 97 - 113
  • [19] The effects of 4-aminopyridine on motor evoked potentials in multiple sclerosis
    Miyoshi, T
    Fujihara, K
    NEUROLOGY, 1998, 50 (04) : A146 - A147
  • [20] 10 Questions About 4-Aminopyridine and the Treatment of Multiple Sclerosis
    Bever, Christopher T., Jr.
    NEUROLOGIST, 2009, 15 (03) : 161 - 162
12345